Skip to content

EQIRIS

Active Risk: not assessed
Public limited companyfounded 2018active for 7 yearsBoomsesteenweg 223, 2610 Antwerp, BelgiumKBO/BCE: BE 0716.669.454

Directors

Directors
6 directors, 3 in day-to-day management, last change in 2026

Board 6

Bernard Heintz
Director · since 19-12-2023 · 6-year term from 2026 · listed in the 2025 annual accounts, filed on 30-06-2026
Current
MOVENDIS
Director · since 19-12-2023 · 6-year term from 2026 · Private limited company · permanent representative: Kathleen Moons · also on the board of 1 other company · listed in the 2025 annual accounts, filed on 30-06-2026
Current
Nicholas Coton
Director · appointed by deed of 04-03-2026 · 6-year term from 2026
Current
Guilia Mazza
Director · appointed by deed of 04-11-2026 · 6-year term from 2026
Current
Peter Byloos
Director · appointed by deed of 04-11-2026
Current
Lode Vlaminck
Director · appointed by deed of 04-11-2026 · 6-year term from 2026
Current

Day-to-day management 3

MERTENS Erik Louis Juliaan Ghislain
Managing director · appointed by deed of 23-01-2024 · earlier director, from 19-12-2023 to 23-01-2024
Current
MOVENDIS
Managing director · appointed by deed of 04-03-2026 · Private limited company · permanent representative: Kathleen Moons
Current
Merel Venneman
Day-to-day manager · appointed by deed of 04-11-2026 · 6-year term from 2026
Current
Permanent representatives 1
Kathleen Moons
Permanent representative · appointed by deed of 23-01-2024 · for MOVENDIS
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“De raad van bestuur en de gedelegeerden tot het dagelijks bestuur, deze laatsten binnen de grenzen van dit bestuur, mogen bijzondere machten…”
deed of 09-02-2026

Owners and capital

Shareholders

1 owner

Chain of control

  1. Signifeye 100%
  2. EQIRIS

Owners 1

Owners through the years 2023 to 2025
Owners through the years
Name202320242025
Signifeye 90%100%

Source: lists of holdings in the owners' accounts

Capital transactions

Capital over time
  1. 09-02-2026 Capital stated in 2 deeds · €8,290,000 · 13,345,000 shares
  2. 26-10-2022 Capital increase of €1,065,000 · to €8,290,000 · 1,065,000 new shares · in cash
  3. 06-01-2022 Capital increase of €1,100,000 · to €7,225,000 · 1,100,000 new shares · in cash

Mandate history

27 people, 8 in office
Show
  • Board
  • Day-to-day management
  • mandate already running before its first mention
  • end not dated
Mandates per person, with start and end dates
Name Functions and periods
Bernard Heintz
  • Director, since before 02-02-2026
Nicholas Coton
  • Director, appointed by deed of 04-03-2026, still in office
Guilia Mazza
  • Director, appointed by deed of 04-11-2026, still in office
Peter Byloos
  • Director, appointed by deed of 04-11-2026, still in office
Lode Vlaminck
  • Director, appointed by deed of 04-11-2026, still in office
MERTENS Erik Louis Juliaan Ghislain
  • Director, appointed by deed of 23-01-2024, until 23-01-2024
  • Managing director, appointed by deed of 23-01-2024, still in office
MOVENDIS
  • Director, from 19-12-2023 to 01-09-2026
  • Managing director, appointed by deed of 23-01-2024, still in office
Merel Venneman
  • Day-to-day manager, appointed by deed of 04-11-2026, still in office
Nicolas Coton
  • Director, until 01-09-2026
Ann Haustermans
  • Director, appointed by deed of 18-08-2025, until 02-02-2026
Erik Mertens
  • Managing director, until 02-02-2026
Fernand De Wilde
  • Director, until 02-02-2026
Frank Kesteloot
  • Director, until 02-02-2026
Huib Lodewijks
  • Director, appointed by deed of 23-01-2024, until 02-02-2026
Maria Dieltiëns
  • Director, until 02-02-2026
MED.OPHTA
  • Director, appointed by deed of 11-12-2025, until 02-02-2026
Signifeye
  • Director, appointed by deed of 23-01-2024, until 02-02-2026
  • Director, appointed by deed of 23-01-2024, no longer listed in the 2025 annual accounts
VRYGHEM Jérôme
  • Class A director, appointed by deed of 17-09-2021, until 23-01-2024
  • Director, until 02-02-2026
DE WILDE Fernand André Marie
  • Director, appointed by deed of 23-01-2024, no longer listed in the 2025 annual accounts
DIELTIËNS Maria Anna
  • Class A director, appointed by deed of 26-10-2022, until 23-01-2024
HEINTZ Bernard Emmanuel
  • Director, appointed by deed of 23-01-2024, until 23-01-2024
ILAT
  • Director, until 23-01-2024
Kathleen Moons
  • Class A director, appointed by deed of 26-10-2022, until 23-01-2024
  • Managing director, appointed by deed of 30-11-2022, ended, last mentioned on 30-11-2022
KESTELOOT Frank Jozef Alexander
  • Class A director, appointed by deed of 06-01-2022, until 23-01-2024
NIJS Ivo Elisa Godfried
  • Director, until 23-01-2024
Prime Management BV
  • Director, appointed by deed of 11-04-2022, until 23-01-2024
DONK INVEST
  • Director, until 03-06-2022

Articles of association

Board and representation

Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
“Alle handelingen nodig of dienstig tot verwezenlijking voorwerp, niet strijdig met artikelen Code Medische Deontologie”

deed of 09-02-2026 (in Dutch)

Capital, shares and profit

Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
“Tenzij uitdrukkelijk anders bepaald in statuten of Aandeelhoudersovereenkomst, soort reeds gehouden door overnemende Aandeelhouder”

deed of 26-10-2022 (in Dutch)

Audit, dissolution and liquidation

Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Algemene vergadering bepaalt wijze vereffening overeenkomstig wettelijke bepalingen bij ontbinding, beroep op artsen voor zaken persoonlijke…”

deed of 09-02-2026 (in Dutch)

Next steps